BYD(002594) 搜狐财经·2025-04-27 02:35Core Viewpoint - Anuo Youda Gene Technology (Beijing) Co., Ltd. has submitted an IPO application to the Hong Kong Stock Exchange, backed by notable investors including Xia Zuoquan, a co-founder of BYD [2][4]. Company Overview - Anuo Youda focuses on molecular diagnostics, particularly in the IVD (in vitro diagnostics) medical device sector and multi-omics life science research services [3]. - The company was founded in April 2012 with initial funding from Xia Zuoquan, who provided several million yuan and holds 93.75% of the company's shares [4]. Investment Background - Xia Zuoquan is known for his early investment in BYD, which yielded over 10,000 times returns, and he currently holds 2.84% of BYD shares valued at over 30 billion yuan [4]. - Since its inception, Anuo Youda has raised a total of 1.539 billion yuan through six funding rounds, with investors including China Life, Northern Light Venture Capital, Guotai Junan, Ping An Group, and Gao Tejia Investment [5]. Shareholder Structure - As of the latest equity change in October 2022, Anuo Youda's valuation is approximately 4.05 billion yuan [6]. - Before the IPO, Xia Zuoquan directly held 9.95% of Anuo Youda's shares, valued at about 398 million yuan, with a return rate exceeding 40 times [7]. Recent Share Transactions - Early investors have begun to cash out as Anuo Youda's valuation increases, with notable transactions including Northern Light selling shares for 100 million yuan in 2017 and 171 million yuan in 2020 [9].